/
2025-06-19: DEUSG Virtual

2025-06-19: DEUSG Virtual

2025-Jun-19

Meeting Details

Date & Time: 19th June 2025, 11am UTC

Objectives

  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:

@Linda Bird @Karin Drivenes @Dion McMurtrie @Guillermo Reynoso @Michael Keary @Dion McMurtrie @Guillermo Reynoso @Aditya Parnandi @ana.paredes Benny Van Bruwaene @Claudie Sombie @Colin Macfarlane @Eddie Mills @Elisabeth Serrot @Emma Melhuish @Frances Ferrera Ger Gahan @Hanne Fjeldstad Johansen @Ian Spiers Jaya Sonavane Jessica MacDougall

@Joanna Hand Joanna Vasse @Juan José Ortega @Julie Boutin Julien Montreuil @Stout, Justin @Karen Rees @Krista Lilly Laila Barrouhou Maria Gomez @Maria Yunes @Megan Berry @Shane Byrnes @Alejandro Lopez Osornio @Nicola Ingram @Noelle Horan @patricia houghton @Paul Wright @Former user (Deleted) @Stuart Abbott @Victoire Caryn @Wei Zhou @Yongsheng Gao 



Zoom Link

Link: Zoom Link

Meeting ID: 85802638911

Passcode: 223446

Meeting Recording

Link: https://snomed.zoom.us/rec/share/haDDBYEy_Zp8ry9Gq0aUj-djWHRMJYHCOpIXVR7mmuhfsL6gsK_fXUZK4RTbqv94.mfGCsVRvicjpX0Kc

Passcode: *4F0MCL!

Discussion items                                              

Description

Mins

Owner

Notes & Actions

Description

Mins

Owner

Notes & Actions

1

Opening

2 min

@Alejandro Lopez Osornio @Shane Byrnes 

Welcome & Notification of Recording

2

Hydration Subsumption (incl. less granular Clinical Drug)

50 min

@Canada

@All

  • Proposal from Canada

  • Group discussion on options



Meeting Notes

Discussion on options proposed for managing hydration subsumption:

  1. Less granular Clinical Drug - beneficial for other reasons, but likely a more complex discussion and piece of work

  2. CGI - complex in terms of modelling, and a workaround that may be replaced by a less granular clinical drug

  3. Solvate modification to substances - presents good option to manage the current challenge. Areas such as concept definitions, role chains, PAIs that are also BoSS, and challenging substances need to be worked through.

Canada will share list of c.200 known hydrated substances - to be used by group to explore approach to option 3 and help identify possible challenging cases. Examples highlighted included choral hydrate, caffeine injection, pramipexole, tacrolimus.  

3

Substances Co-Ordination Update

8 min

@Alejandro Lopez Osornio 

  • Combined substances sheet link has been updated: HERE.

  • Update on substances in multiple extensions (circa. 80)

  • Update on substances in single extensions

4

AOB



@Shane Byrnes 

Update from Nicki on Patch Strength representation briefing note - It has now moved to implementation.

5

Topic Backlog





  • Hydration Subsumption

  • Less Granular Clinical Drug

  • Elemental Substances (Matt, AUS)

  • Dose Form Intended Site v Route of Administration (BEL)

  • Substances Co-ordination

    • Step 1: Substances in multiple extensions

    • Step 2: Substances in one extension

    • Step 3: Ongoing Substance Co-ordination (capturing at regulator level)

  • Medication Stopped v Medication Discontinued (Karen, SI)

  • Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work)

  • Value range of a |Has container type| attribute (Linda, CA)

  • Drug extension MRCM attributes (CA, AUS)

  • Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS) 

  • Group Input on Patch Strength Representation

  File Modified
No files shared here yet.

Copyright © 2025, SNOMED International